Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Timothy J. Fischer"'
Autor:
Timothy J. Fischer, Cynthia Ann Lloyd, Francesco Viola, Kiev R. Blasier, Elisa A. Ferrante, Thomas B. Givens
Publikováno v:
Anesthesia & Analgesia. 123:1372-1379
Major surgical procedures often result in significant intra- and postoperative bleeding. The ability to identify the cause of the bleeding has the potential to reduce the transfusion of blood products and improve patient care. We present a novel devi
Autor:
Amy K. Saenger, Suzette M. Warner, Margery A. Connelly, Timothy J. Fischer, Irina Shalaurova, Elias J. Jeyarajah, Paul J. Braun, Steven P. Matyus, Justyna Wolak-Dinsmore
Publikováno v:
Clinical Biochemistry. 48:148-155
Objectives Nuclear magnetic resonance (NMR) spectroscopy has been successfully applied to the measurement of high-density lipoprotein (HDL) particles, providing particle concentrations for total HDL particle number (HDL-P), HDL subclasses (small, med
Autor:
Timothy J. Fischer, Lorraine M. King, Eric P. Dixon, Heather Passineau, Charlotte A. Brown, Petter Grønn, Shauna N. Hay, Jalil Hariri, Douglas P. Malinowski, Hema Doobay, Hanne Skomedal
Publikováno v:
Journal of Virological Methods. 185:199-203
Several commercial HPV ancillary tests are available for detection of E6/E7 RNA. It is not clear how storage of a cervical Pap affects the analytical and clinical performance of the PreTect™ HPV-Proofer assay. To investigate the qualitative perform
Autor:
Timothy J. Fischer, Charlotte A. Brown, Douglas P. Malinowski, Eric P. Dixon, Hema Doobay, Karen L. Lenz
Publikováno v:
Journal of Clinical Virology. 48:31-35
Background The AMPLICOR HPV Test has been validated for use with cervical cells collected in liquid-based preservative fluids, such as BD SurePath. It is currently recommended, however, that residual BD SurePath samples be stored at 4 °C prior to te
Autor:
Andrew Berchuck, Timothy J. Fischer, Jennifer M. Rubatt, Robert L. Cheek, Clark M. Whitehead, Qin He, John W. Groelke, Douglas P. Malinowski, Laura J. Havrilesky
Publikováno v:
Gynecologic Oncology. 110:374-382
Objective To determine the utility of novel combinations of biomarkers, using both a one-step and two-step assay format, to distinguish serum of early ovarian cancer patients from that of healthy controls and to discern the utility of these biomarker
Autor:
Elias J. Jeyarajah, Yuan Xu, Paul J. Braun, Thomas S. Clement, Margery A. Connelly, Irina Shalaurova, Justyna Wolak-Dinsmore, Suzette M. Warner, Steven P. Matyus, Timothy J. Fischer
Publikováno v:
Clinical biochemistry. 47(16-17)
Background The Vantera Clinical Analyzer was developed to enable fully-automated, high-throughput nuclear magnetic resonance (NMR) spectroscopy measurements in a clinical laboratory setting. NMR-measured low-density lipoprotein particle number (LDL-P
Publikováno v:
Medical & Biological Engineering & Computing. 35:760-763
An embedded knowledge-based system has been developed to determine the optimum sequence for assays performed on a random access coagulation analyser. This knowledge base is in the form of a set of rules describing penalties associated with certain se
Autor:
Lisa Beck, Paul J. Braun, Andrew G. Stead, Thomas B. Givens, Robert J Swan, Sheila A Gooch, Timothy J. Fischer
Publikováno v:
Thrombosis and Haemostasis. 78:1079-1087
SummaryChanges in characteristics of optical transmittance data from coagulation assays were examined as a function of concentration of coagulation proteins or anticoagulants. Transmittance data were collected for activated partial thromboplastin tim
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 511
Molecular diagnostic adjuncts could improve the specificity of cervical cancer screening. Since persistent infection with human papillomavirus (HPV) is found in virtually 100% of cervical cancer cases, testing for markers of HPV integration may have
Autor:
Timothy J. Fischer, Donna L. Dehn, Kenneth R. Shroyer, Douglas P. Malinowski, Adriann J. Taylor
Publikováno v:
Methods in Molecular Biology ISBN: 9781934115145
Molecular diagnostic adjuncts could improve the specificity of cervical cancer screening. Since persistent infection with human papillomavirus (HPV) is found in virtually 100% of cervical cancer cases, testing for markers of HPV integration may have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4d9449f72c3f7ba31c28c25027cf439
https://doi.org/10.1007/978-1-59745-447-6_12
https://doi.org/10.1007/978-1-59745-447-6_12